Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer
Journal of Clinical Oncology2018Vol. 36(29), pp. 2943–2949
Citations Over TimeTop 1% of 2018 papers
Karen E. Hoffman, Khinh Ranh Voong, Lawrence B. Levy, Pamela K. Allen, Seungtaek Choi, Pamela J. Schlembach, Andrew K. Lee, Sean E. McGuire, Quynh Nguyen, Thomas J. Pugh, Steven J. Frank, Rajat J. Kudchadker, Weiliang Du, Deborah A. Kuban
Abstract
The results of this randomized trial demonstrate superior cancer control for men with localized prostate cancer who receive dose-escalated moderately hypofractionation radiotherapy while shortening treatment duration.
Related Papers
- → Efficacy of prenatal ultrasonography in diagnosing urogenital developmental anomalies in newborns(2014)13 cited
- → Urogenital anomalies associated with anorectal malformations in children(2007)3 cited
- → Trauma of the Lower Genitourinary Tract(1998)3 cited
- → MP-16.06 Changes in Body Composition, Development of Metabolic Syndrome (X) and Pathological Fractures in Men on Long-Term Androgen Deprivation Therapy(2011)
- → Genitourinary Operations in Trauma(2019)